SB
Shankar Baban Dhanawade
About Shankar Baban Dhanawade
Data last updated:
Shankar Baban Dhanawade is a Director at Investbell Nidhi Limited (since 2021) and Designated Partner at Kenzion Pharmaceuticals Llp (since 2023). The companies operate in Financial Services and Business Services. The largest current company by reported revenue is Investbell Nidhi Limited at ₹58.3 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Investbell Nidhi Limited U65990MH2021PLN354047 | Director | 23 Jan 2021 | 2021 | ₹58.3 Lakh (FY 2025) | Active |
| Kenzion Pharmaceuticals Llp ACB-3938 | Designated Partner | 29 May 2023 | 2023 | Active |
Board colleagues of Shankar Baban Dhanawade
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shashikant Vitthal Beloshe | 09041570 | Investbell Nidhi Limited , Kenzion Pharmaceuticals Llp | Director |
| Tanaji Vitthal Beloshe | 09041571 | Investbell Nidhi Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shankar Baban Dhanawade
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shankar Baban Dhanawade
Shankar Baban Dhanawade currently holds 2 directorships: Investbell Nidhi Limited (Director, since 23 Jan 2021, revenue ₹58.3 Lakh (FY 2025)); Kenzion Pharmaceuticals Llp (Designated Partner, since 29 May 2023).
Shankar Baban Dhanawade was first appointed on 23 Jan 2021 as Director at Investbell Nidhi Limited. The most recent appointment on record is 29 May 2023 at Kenzion Pharmaceuticals Llp.
The current boards of Shankar Baban Dhanawade's companies include Shashikant Vitthal Beloshe (Investbell Nidhi Limited), Tanaji Vitthal Beloshe (Investbell Nidhi Limited).